Abstract A070: Clinical application of functional precision medicine for pancreatic cancer enables personalized treatment prioritization and identification of RAS-targeted combinations
The successful clinical implementation of Optim.AI™ for pancreatic cancer within a CAP/CLIA laboratory is demonstrated, providing actionable treatment recommendations within seven business days and high concordance with observed clinical resistance supports its potential to improve treatment selection.